D
Spero Therapeutics, Inc. SPRO
$1.87 $0.010.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 14.19M 5.87M 15.04M 13.47M 10.20M
Total Other Revenue -- -- -- -- --
Total Revenue 14.19M 5.87M 15.04M 13.47M 10.20M
Cost of Revenue 10.67M 13.61M 92.51M 703.00K 23.73M
Gross Profit 3.52M -7.73M -62.42M 12.77M -13.53M
SG&A Expenses 5.88M 6.82M 7.06M 5.20M 5.53M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 16.55M 20.43M 35.89M 32.06M 29.26M
Operating Income -2.36M -14.56M -20.85M -18.59M -19.06M
Income Before Tax -1.70M -13.87M -20.60M -17.44M -17.86M
Income Tax Expenses -- -- 290.00K -290.00K --
Earnings from Continuing Operations -1.70M -13.87M -20.89M -17.15M -17.86M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -1.70M -13.87M -20.89M -17.15M -17.86M
EBIT -2.36M -14.56M -20.85M -18.59M -19.06M
EBITDA -2.36M -14.56M -20.85M -18.59M -19.06M
EPS Basic -0.03 -0.25 -0.38 -0.32 -0.33
Normalized Basic EPS -0.02 -0.15 -0.23 -0.20 -0.21
EPS Diluted -0.03 -0.25 -0.38 -0.32 -0.33
Normalized Diluted EPS -0.02 -0.15 -0.23 -0.20 -0.21
Average Basic Shares Outstanding 56.03M 55.38M 54.54M 54.12M 53.96M
Average Diluted Shares Outstanding 56.03M 55.38M 54.54M 54.12M 53.96M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --